BridgeBio Pharma, Inc. (BBIO) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
3160 PORTER DR. PALO ALTO, CA 94304 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 681,101 | 434,884 | 471,922 | 836,663 | 607,093 | 545,993 | |||
| Cash and cash equivalent | 681,101 | 375,935 | 376,689 | 393,772 | 356,082 | 363,773 | |||
| Short-term investments | 58,949 | 95,233 | 442,891 | 251,011 | 182,220 | ||||
| Restricted cash and investments | 126 | 16,653 | 37,930 | 177 | |||||
| Receivables | 4,722 | 1,751 | 17,079 | 19,749 | |||||
| Inventory, net of allowances, customer advances and progress billings | |||||||||
| Inventory | |||||||||
| Other undisclosed current assets | 34,743 | 24,305 | 21,922 | 32,269 | 35,731 | 22,629 | |||
| Total current assets: | 720,692 | 477,593 | 548,853 | 888,858 | 642,824 | 568,622 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 5,767 | 8,027 | 10,678 | 15,907 | 16,508 | ||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 7,011 | 11,816 | 14,569 | 30,066 | 20,325 | 5,625 | |||
| Long-term investments and receivables | 143,747 | 31,144 | |||||||
| Long-term investments | 143,747 | 31,144 | |||||||
| Intangible asset, including goodwill, after accumulated amortization | 23,926 | 26,319 | 28,712 | 44,934 | |||||
| Intangible asset, excluding goodwill, after accumulated amortization | 23,926 | 26,319 | 28,712 | 44,934 | |||||
| Other noncurrent assets | 18,195 | 22,625 | 20,224 | 33,027 | 23,931 | 26,288 | |||
| Total noncurrent assets: | 198,646 | 68,787 | 74,183 | 123,934 | 60,764 | 63,057 | |||
| TOTAL ASSETS: | 919,338 | 546,380 | 623,036 | 1,012,792 | 703,588 | 631,679 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 99,279 | 97,855 | 69,794 | 85,993 | 57,555 | 27,411 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 37,041 | 29,682 | 13,317 | ||
| Accounts payable | 9,618 | 10,655 | 11,558 | 11,884 | 8,945 | 8,852 | |||
| Accrued liabilities | 89,661 | 87,200 | 58,236 | 37,068 | 18,928 | 5,242 | |||
| Deferred revenue | 14,604 | 6,096 | 8,156 | ||||||
| Debt | 295 | 1,586 | 8,000 | ||||||
| Restructuring reserve | 1,848 | 55 | 6,826 | ||||||
| Other liabilities | |||||||||
| Other undisclosed current liabilities | 38,669 | 39,838 | 36,652 | 48,781 | 36,507 | 24,974 | |||
| Total current liabilities: | 154,400 | 143,844 | 121,428 | 135,069 | 95,648 | 60,385 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 437,337 | 446,445 | 430,993 | 449,425 | 108,671 | 91,791 | |||
| Long-term debt, excluding current maturities | 437,337 | 446,445 | 430,993 | 430,752 | 92,421 | 91,791 | |||
| Finance lease, liability | 1,245 | 1,573 | |||||||
| Liabilities, other than long-term debt | 22,077 | 18,342 | 38,917 | 22,069 | 9,520 | 3,527 | |||
| Deferred revenue | 17,095 | ||||||||
| Other liabilities | 286 | 9,361 | 26,643 | 22,069 | 9,520 | 3,527 | |||
| Operating lease, liability | 4,696 | 8,981 | 12,274 | 17,428 | 14,677 | ||||
| Other undisclosed noncurrent liabilities | 1,763,136 | 1,280,284 | 1,276,622 | 1,271,808 | 381,863 | ||||
| Total noncurrent liabilities: | 2,222,550 | 1,745,071 | 1,746,532 | 1,743,302 | 500,054 | 95,318 | |||
| Total liabilities: | 2,376,950 | 1,888,915 | 1,867,960 | 1,878,371 | 595,702 | 155,703 | |||
| Temporary equity, including noncontrolling interest | 1,423 | 1,630 | 2,243 | ||||||
| Equity | |||||||||
| Equity, attributable to parent | (1,467,904) | (1,354,257) | (1,254,617) | (870,414) | 57,906 | 408,454 | |||
| Common stock | 196 | 181 | 157 | 154 | 125 | 124 | |||
| Treasury stock, value | (275,000) | (275,000) | (275,000) | (275,000) | (75,000) | ||||
| Additional paid in capital | 1,903,155 | 1,481,032 | 938,703 | 841,530 | 1,021,344 | 848,107 | |||
| Accumulated other comprehensive income (loss) | 8 | 31 | (328) | (132) | 192 | 254 | |||
| Accumulated deficit | (3,096,263) | (2,560,501) | (1,918,149) | (1,436,966) | (888,755) | (440,031) | |||
| Equity, attributable to noncontrolling interest | 10,150 | 11,244 | 11,282 | 3,412 | 48,350 | 65,279 | |||
| Total equity: | (1,457,754) | (1,343,013) | (1,243,335) | (867,002) | 106,256 | 473,733 | |||
| Other undisclosed liabilities and equity | 142 | 478 | (1,589) | ||||||
| TOTAL LIABILITIES AND EQUITY: | 919,338 | 546,380 | 623,036 | 1,012,792 | 703,588 | 631,679 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 221,902 | 9,303 | 77,648 | 69,716 | 8,249 | 40,560 | ||
| Gain on disposition of assets for financial service operations | 8,136 | 8,668 | 3,731 | 2,206 | ||||
| Cost of revenue | (3,878) | (2,446) | (47,199) | (3,114) | ||||
| Cost of product and service sold | (2,735) | |||||||
| Gross profit: | 218,024 | 6,857 | 30,449 | 66,602 | 8,249 | 40,560 | ||
| Operating expenses | (795,392) | (606,301) | (542,651) | (643,234) | (482,731) | (306,800) | ||
| Other undisclosed operating loss | (15,605) | (7,926) | ||||||
| Operating loss: | (592,973) | (607,370) | (512,202) | (576,632) | (474,482) | (266,240) | ||
| Nonoperating income (expense) | 50,779 | (45,881) | 27,550 | (9,822) | (31,006) | (22,345) | ||
| Investment income, nonoperating | 195,570 | 18,038 | 7,542 | 1,133 | 4,015 | 8,915 | ||
| Other nonoperating income (expense) | 12,272 | 17,370 | (7,500) | 35,823 | 1,634 | (1,210) | ||
| Interest and debt expense | (26,590) | (81,289) | (80,438) | (50,115) | (36,655) | (8,765) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 1,047,631 | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (568,784) | (734,540) | (565,090) | (636,569) | 505,488 | (297,350) | ||
| Loss from equity method investments | (20,869) | |||||||
| Other undisclosed income from continuing operations before income taxes | 26,590 | |||||||
| Income (loss) from continuing operations before income taxes: | (542,194) | (734,540) | (565,090) | (636,569) | 505,488 | (318,219) | ||
| Income tax expense | (1,153) | |||||||
| Income (loss) from continuing operations: | (543,347) | (734,540) | (565,090) | (636,569) | 505,488 | (318,219) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (636,569) | 505,488 | (318,219) | |
| Other undisclosed net income (loss) | 81,289 | 80,438 | 50,115 | (1,010,976) | 29,634 | |||
| Net loss: | (543,347) | (653,251) | (484,652) | (586,454) | (505,488) | (288,585) | ||
| Net income attributable to noncontrolling interest | 7,585 | 10,049 | 3,469 | 23,915 | 56,764 | 27,998 | ||
| Net loss available to common stockholders, diluted: | (535,762) | (643,202) | (481,183) | (562,539) | (448,724) | (260,587) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (543,347) | (653,251) | (484,652) | (586,454) | (505,488) | (288,585) | ||
| Other undisclosed comprehensive income (loss) | (23) | 359 | (196) | (324) | (62) | 254 | ||
| Comprehensive loss: | (543,370) | (652,892) | (484,848) | (586,778) | (505,550) | (288,331) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 7,585 | 10,049 | 3,469 | 23,915 | 56,764 | 27,998 | ||
| Comprehensive loss, net of tax, attributable to parent: | (535,785) | (642,843) | (481,379) | (562,863) | (448,786) | (260,333) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.